Vakzine Projekt Management GmbH
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 2002-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
8
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic
- Conditions
- Infection, Respiratory Tract
- First Posted Date
- 2020-06-17
- Last Posted Date
- 2021-10-26
- Lead Sponsor
- Vakzine Projekt Management GmbH
- Target Recruit Count
- 2038
- Registration Number
- NCT04435379
- Locations
- 🇩🇪
Hautarztpraxis Dres. Leitz & Kollegen, Stuttgart, Baden-Württemberg, Germany
🇩🇪MECS Cottbus GmbH, Cottbus, Brandenburg, Germany
🇩🇪Studienzentrum Dr. Keller, Frankfurt, Hessen, Germany
Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic
- Conditions
- Infection, Respiratory Tract
- First Posted Date
- 2020-05-13
- Last Posted Date
- 2020-09-30
- Lead Sponsor
- Vakzine Projekt Management GmbH
- Target Recruit Count
- 59
- Registration Number
- NCT04387409
- Locations
- 🇩🇪
Ludwig-Maximilians-Universität München, München, Bayern, Germany
🇩🇪Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany
🇩🇪SocraTec R&D GmbH, Erfurt, Thüringen, Germany
Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa
- Conditions
- Tuberculosis
- First Posted Date
- 2011-11-28
- Last Posted Date
- 2013-10-29
- Lead Sponsor
- Vakzine Projekt Management GmbH
- Target Recruit Count
- 48
- Registration Number
- NCT01479972
- Locations
- 🇿🇦
Children's Infectious Diseases Clinical Research Unit, Tygerberg Hospital, Cape Town, South Africa
Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison to BCG in Healthy Volunteers in South Africa
- Conditions
- Tuberculosis
- First Posted Date
- 2010-04-29
- Last Posted Date
- 2011-11-21
- Lead Sponsor
- Vakzine Projekt Management GmbH
- Target Recruit Count
- 24
- Registration Number
- NCT01113281
- Locations
- 🇿🇦
Farmovs-Parexel, Bloemfontein, South Africa
Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison With BCG in Healthy Male Volunteers
- Conditions
- TuberculosisHealthy
- First Posted Date
- 2008-09-09
- Last Posted Date
- 2010-05-20
- Lead Sponsor
- Vakzine Projekt Management GmbH
- Target Recruit Count
- 80
- Registration Number
- NCT00749034
- Locations
- 🇩🇪
Focus Clinical Drug Development GmbH, Neuss, Germany